NCT07598968已完成1 期
A Two-arm, Open-label, Single-sequence, Multiple Oral Dosings, Cross-over Design Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 35
- 试验地点
- 1
研究概览
简要总结
This clinical trial is a two-arm, open-label, single-sequence, multiple oral dosings, cross-over design clinical trial to evaluate the safety and pharmacokinetic characteristics of HL1113-R1 and HL1113-R2 in healthy adult volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Healthy adult subjects aged ≥19 years at the time of screening
- •Subjects with no clinically significant congenital or chronic diseases based on screening, and no clinically significant findings on internal medicine examination (including, if necessary, electroencephalogram [EEG], electrocardiogram [ECG], chest examination, upper gastrointestinal endoscopy, or gastrointestinal radiography)
排除标准
- •Subjects who have received medications known to markedly induce or inhibit drug-metabolizing enzymes (e.g., barbiturates) within 30 days prior to the screening visit
- •Subjects who have received any medications that may affect the outcome of the study within 10 days prior to the screening visit
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting StateDiabete Type 2HypertensionNCT07568652Hanlim Pharm. Co., Ltd.37
招募中
不适用
Retrograde Ascending Dissection: Intraluminal Aortic TherapyNCT07405242Ruijin Hospital149
已完成
不适用
Bioequivalence study of Propiomazine Tablets 25 mg in healthy, adult, human Subjects under fasting conditions.CTRI/2024/04/066196Centaur Pharmaceuticals Pvt. Ltd40
尚未招募
不适用
Bioequivalence study of Gabapentin and Nortriptyline hydrochloride tablets of Intas pharmaceuticals Ltd, India to GABATOR NT in normal, healthy, adult, human subjectsCTRI/2024/08/073151Intas Pharmaceuticals Ltd60
尚未招募
1 期
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor SubjectsNCT07446153Jiangsu HengRui Medicine Co., Ltd.282